SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
RedHill Biopharma Ltd. Announces a Successful Pivotal Bioequivalence Trial with RHB-102 for the Prevention of Nausea and Vomiting in Cancer Patients